Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Generic medicines accounted for 62% of all medicines prescribed in Europe in 2016

New data just released in the two largest global pharma markets show the substantial and growing level of savings made possible by increased use of generic medicines. HOLZKIRCHEN, 21-Jun-2017 — /EuropaWire/ — Generic medicines accounted for 62% of all medicines prescribed … Read the full press release

Sandoz: European Commission approves Rixathon for use in Europe

European Commission approves Sandoz Rixathon® to treat blood cancers and immunological diseases. Approval expected to broaden patient access to biologics and enable budget-constrained healthcare systems to reallocate resources to other healthcare priorities. Sandoz now has four biosimilars approved in Europe … Read the full press release

GSK: Benlysta plus standard of care prolonged control of disease activity in patients with active systemic lupus erythematosus (SLE)

Final efficacy and safety results from phase II continuation study Madrid, Spain and London, UK, 19-Jun-2017 — /EuropaWire/ — GSK today announced results from a 10-year continuation study, which showed that Benlysta (belimumab) plus standard of care prolonged control of disease … Read the full press release

China: SGS to undertake extractables and leachables (E&L) testing at its Shanghai laboratory

GENEVA, 16-Jun-2017 — /EuropaWire/ — SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced that it has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. Its investment includes the … Read the full press release

Boehringer Ingelheim To Focus on Innovative Digital Solutions in Healthcare With Digital Lab “BI X”

New start-up as platform for digital transformation in data science, agile software development and user experience design Improvement of  human and animal health with innovative digital solutions BI X offers 50 new jobs at the company’s headquarters Investment of 10 … Read the full press release

Basilea Pharmaceutica updates on clinical phase 1/2a program with its anticancer drug candidate BAL101553 at American Society of Clinical Oncology (ASCO)

BASEL, 09-Jun-2017 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that updates were presented on the ongoing clinical phase 1/2a program with its anticancer drug candidate BAL101553, a novel tumor checkpoint controller, at the American Society of Clinical Oncology … Read the full press release

U.S. FDA premarket approval for QIAGEN’s automated artus® CMV QS-RGQ MDx kit for use on its QIAsymphony platform

High-throughput application of artus CMV QS-RGQ MDx Kit on QIAsymphony streamlines critical and frequently performed viral infection test for transplant patients Germantown, Maryland, and Hilden, Germany, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has … Read the full press release

QIAGEN receives worldwide license from The Johns Hopkins University for biomarkers for immune-oncology therapies in cancer treatment

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide … Read the full press release

Bristol-Myers Squibb and QIAGEN to explore NGS technology to develop GEPs for I-O therapies in cancer treatment

NEW YORK and HILDEN, Germany, 06-Jun-2017 — /EuropaWire/ — Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  … Read the full press release

Shire to present ADHD research at the 170th Annual Meeting of the American Psychiatric Association (APA) in San Diego

Latest Research Supports Greater Understanding of the Evolving Needs of Adults with ADHD Lexington, M.A., 18-May-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) will present research on the evolving needs of adults living with Attention-Deficit/Hyperactivity Disorder (ADHD) at the … Read the full press release

Changes to Actelion’s executive team to take effect upon closing of the transaction with Johnson & Johnson

ALLSCHWIL/BASEL, SWITZERLAND, 17-May-2017 — /EuropaWire/ — Actelion Ltd (SIX: ATLN) today announced changes to its executive team that would only take effect upon closing of the transaction with Johnson & Johnson expected towards the end of the second quarter 2017. … Read the full press release

QIAGEN N.V. forms joint venture with Maccura Biotechnology Co., Ltd., a leading in vitro diagnostics (IVD) company in China

Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world’s first complete Sample to Insight NGS solution in rapidly growing Chinese market Hilden, Germany, and Chengdu, China, 08-May-2017 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt … Read the full press release

University of Bristol: New drug combination that could help thousands of children with arthritis discovered

BRISTOL, 05-May-2017 — /EuropaWire/ — A new drug combination that could help thousands of children with arthritis and prevent them from serious complications, including blindness, has been discovered by researchers and thanks to a trial funded by Arthritis Research UK and … Read the full press release

MEDLAB Series expands its presence into Europe

More than 3,000 medical laboratory industry professionals expected to attend the launch edition of MEDLAB Europe at the Barcelona Congress Centre in Spain Barcelona, Spain, 04-May-2017 — /EuropaWire/ — After many years of operating successful MEDLAB events around Africa, Asia … Read the full press release

Merck presented new data on efficacy and safety for investigational Cladribine Tablets at the American Academy of Neurology (AAN)

Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo DARMSTADT, 02-May-2017 — /EuropaWire/ — Merck, a leading science and technology company, announced the presentation of new analyses of efficacy and safety data for … Read the full press release

Roche’s Lucentis is the first and only FDA-approved medicine to treat diabetic retinopathy

First and only medicine approved to treat all forms of diabetic retinopathy Granted Priority Review Designation by the FDA based on analysis of results from a National Institutes of Health (NIH)-funded collaborative group study BASEL, 24-Apr-2017 — /EuropaWire/ — Roche (SIX: … Read the full press release

FDA Approves Roche’s TECENTRIQ as initial treatment for certain advanced bladder cancer patients

First and only cancer immunotherapy approved in advanced bladder cancer as initial treatment for those unable to receive cisplatin chemotherapy BASEL, 24-Apr-2017 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) … Read the full press release

New Data on Roche’s OCREVUS To be Presented at AAN

Data presentations will include platform sessions and posters across relapsing multiple sclerosis and primary progressive multiple sclerosis BASEL, 24-Apr-2017 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data on OCREVUS™ (ocrelizumab) in people with relapsing … Read the full press release

New Study Shows Immune System Can Spot Changes in Identity of Cancer Antigens

BIRMINGHAM, 19-Apr-2017 — /EuropaWire/ — A new study has identified novel mechanisms whereby T cells may be able to distinguish an emerging class of targets specifically increased on cancer cells. The study, carried out by researchers from the University of Birmingham … Read the full press release

Novartis Reinforces Commitment to Sandoz With Major Investment in Business

Total investment of EUR 105 million in Prevalje site reinforces commitment to largest Sandoz business, Anti-Infectives, and single largest global product, broad-spectrum antibiotic amoxicillin-clavulanic acid. The investment will bring 150 new jobs, more than doubling the number of employees at … Read the full press release

Relieve the Stress from Asthma Management with New MyAsthma App

NOTTINGHAM, 18-Apr-2017 — /EuropaWire/ — A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK). The MyAsthma app has been launched … Read the full press release

GSK will make change to its financial reporting from Q1 2017

LONDON, 12-Apr-2017 — /EuropaWire/ — GSK keeps its financial reporting framework under regular review to ensure that it remains current and in line with both the latest regulatory requirements and developing best practice within the Pharmaceutical industry. As a result of … Read the full press release

Milestone for the diagnosis of inflammatory bowel disease

Clinicians at the University Hospital Erlangen show how a new laser-based imaging technique termed MSOT can detect inflammation more accurately than current non-invasive diagnostic procedures and thereby help reduce the burden to patients MUNICH, 30-Mar-2017 — /EuropaWire/ — Ulcerative colitis … Read the full press release

PLIVA received three Golden Indexes 2016 awards

ZAGREB, 28-Mar-2017 — /EuropaWire/ — At the award ceremony held on 21 March 2017, Golden Indexes 2016 were awarded to companies that contributed greatly to the quality of students’ lives, education and development in 2016. PLIVA received as many as three … Read the full press release

University of Dundee awarded grant from Innovate UK to create an Antibacterial Drug Discovery Accelerator

Dundee, Scotland, 27-Mar-2017 — /EuropaWire/ — Antimicrobial resistance is one of the greatest threats to global human and animal health – the O’Neill Report published last year stated that, unless we take urgent action, it will be directly responsible for over … Read the full press release

Researchers Start New Clinical Trial for the Treatment of Genetic Blindness

OXFORD, 22-Mar-2017 — /EuropaWire/ — Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible … Read the full press release

VAAM Elects Founder and CEO of Organo Balance as New First Vice President

VAAM aims to turn microbiology research into products which benefit society BERLIN, 22-Mar-2017 — /EuropaWire/ — The founder and CEO of Organobalance GmbH, Prof. Dr. Christine Lang, is the new first vice president of the Association for General and Applied Microbiology … Read the full press release

Regulations Called For Data-sharing Arrangements Between NHS and Google DeepMind

A study of a deal which has allowed Google DeepMind access to millions of healthcare records argues that more needs to be done to regulate such agreements between public sector bodies and private technology firms. CAMBRIDG, 20-Mar-2017 — /EuropaWire/ — … Read the full press release

Dundee, Edinburgh embark on joint Regenerative Medicine Research

DUNDEE, 10-Mar-2017 — /EuropaWire/ — Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better understand the biological processes that could allow the development of new drugs to support tissue regeneration … Read the full press release

Philips is the world’s largest patent applicant for the second consecutive year

Philips filed 2,568 patent applications* at the EPO during 2016 Company maintains number-one position in three strategic patent filing areas: ‘Medical Technology’, ‘Electrical machinery, apparatus, energy’ and ‘Measurement’  AMSTERDAM, 08-Mar-2017 — /EuropaWire/ — Leading health technology company Royal Philips (NYSE: PHG, … Read the full press release